- Home
- BWXT vs SRPT Comparison
BWXT vs SRPT Comparison
Compare BWXT & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWXT
- SRPT
- Stock Information
- Founded
- BWXT 1867
- SRPT 1980
- Country
- BWXT United States
- SRPT United States
- Employees
- BWXT N/A
- SRPT N/A
- Industry
- BWXT
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- BWXT
- SRPT Health Care
- Exchange
- BWXT Nasdaq
- SRPT Nasdaq
- Market Cap
- BWXT 10.9B
- SRPT 12.2B
- IPO Year
- BWXT N/A
- SRPT 1997
- Fundamental
- Price
- BWXT $117.24
- SRPT $123.84
- Analyst Decision
- BWXT Strong Buy
- SRPT Buy
- Analyst Count
- BWXT 8
- SRPT 21
- Target Price
- BWXT $124.57
- SRPT $179.38
- AVG Volume (30 Days)
- BWXT 726.0K
- SRPT 1.0M
- Earning Date
- BWXT 11-04-2024
- SRPT 11-06-2024
- Dividend Yield
- BWXT 0.82%
- SRPT N/A
- EPS Growth
- BWXT 24.26
- SRPT N/A
- EPS
- BWXT 3.02
- SRPT 1.22
- Revenue
- BWXT $2,682,902,000.00
- SRPT $1,640,348,000.00
- Revenue This Year
- BWXT $9.56
- SRPT $50.40
- Revenue Next Year
- BWXT $6.33
- SRPT $71.44
- P/E Ratio
- BWXT $39.10
- SRPT $103.94
- Revenue Growth
- BWXT 12.02
- SRPT 48.45
- 52 Week Low
- BWXT $74.69
- SRPT $89.92
- 52 Week High
- BWXT $136.31
- SRPT $173.25
- Technical
- Relative Strength Index (RSI)
- BWXT 36.03
- SRPT 50.01
- Support Level
- BWXT $117.15
- SRPT $122.12
- Resistance Level
- BWXT $124.86
- SRPT $128.73
- Average True Range (ATR)
- BWXT 2.68
- SRPT 3.87
- MACD
- BWXT -1.39
- SRPT -0.15
- Stochastic Oscillator
- BWXT 7.65
- SRPT 11.14
About BWXT BWX Technologies Inc.
BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.